Functional evidence for interaction between prostaglandin EP3 and κ-opioid receptor pathways in tactile pain induced by human immunodeficiency virus type-1 (HIV-1) glycoprotein gp120
- 30 May 2003
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 45 (1), 96-105
- https://doi.org/10.1016/s0028-3908(03)00133-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Characterization of EP receptor subtypes responsible for prostaglandin E2‐induced pain responses by use of EP1 and EP3 receptor knockout miceBritish Journal of Pharmacology, 2001
- Apoptosis Induced by gp120 in the Neocortex of Rat Involves Enhanced Expression of Cyclooxygenase Type 2 and Is Prevented by NMDA Receptor Antagonists and by the 21-Aminosteroid U-74389GBiochemical and Biophysical Research Communications, 2000
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- HIV-1 gp120-Induced Apoptosis in the Rat Neocortex Involves Enhanced Expression of Cyclo-oxygenase Type 2 (COX-2)Biochemical and Biophysical Research Communications, 1998
- HIV‐1 Envelope Proteins gp120 and gp160 Potentiate NMDA‐induced [Ca2+]i Increase, Alter [Ca2+]i Homeostasis and Induce Neurotoxicity in Human Embryonic NeuronsEuropean Journal of Neuroscience, 1995
- Exposure to gp120 of HIV‐1 Induces an Increased Release of Arachidonic Acid in Rat Primary Neuronal Cell Culture Followed by NMDA Receptor‐mediated NeurotoxicityEuropean Journal of Neuroscience, 1995
- Pain in human immunodeficiency virus disease: a reviewPain, 1993
- Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine, noradrenaline, carbachol or midazolam in ratsPain, 1992
- HIV-1 Coat Protein Neurotoxicity Prevented by Calcium Channel AntagonistsScience, 1990
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983